Upgrade to SI Premium - Free Trial

Scotiabank Reiterates Sector Outperform Rating on Biogen (BIIB)

June 12, 2024 10:10 AM
Scotiabank analyst George Farmer reiterated a Sector Outperform rating and $275.00 price target on Biogen (NASDAQ: BIIB).The analyst commented, "Unanimous ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments